Clinical Trial Update: Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of sublingual immunotherapy in patients with atopic dermatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Casa Espirita Terra de Ismael | Conditions: Atopic Dermatitis, Effects of Immunotherapy | Phase 4 | Status: COMPLETED